The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 167,203 | 1,484,400 | SH | SOLE | 1,484,400 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 12,561 | 1,584,000 | SH | SOLE | 1,584,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 22,927 | 940,000 | SH | SOLE | 940,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 44,988 | 358,500 | SH | SOLE | 358,500 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 23,158 | 2,250,500 | SH | SOLE | 2,250,500 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 16,429 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 33,056 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
ALPHA TEKNOVA INC | COM | 02080L102 | 2,373 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 40,154 | 2,621,000 | SH | SOLE | 2,621,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 13,455 | 1,495,000 | SH | SOLE | 1,495,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 64,313 | 943,000 | SH | SOLE | 943,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 8,613 | 104,000 | SH | SOLE | 104,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 142,758 | 1,854,000 | SH | SOLE | 1,854,000 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 5,360 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ATAI LIFE SCIENCES NV | SHS | N0731H103 | 6,493 | 350,987 | SH | SOLE | 350,987 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 112,922 | 3,180,000 | SH | SOLE | 3,180,000 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 5,265 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 3,414 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 13,218 | 4,250,000 | SH | SOLE | 4,250,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 63,679 | 183,900 | SH | SOLE | 183,900 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 85,673 | 882,500 | SH | SOLE | 882,500 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 49,539 | 563,200 | SH | SOLE | 563,200 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 41,050 | 673,400 | SH | SOLE | 673,400 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 9,277 | 1,395,000 | SH | SOLE | 1,395,000 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 37,348 | 654,200 | SH | SOLE | 654,200 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 10,544 | 817,402 | SH | SOLE | 817,402 | 0 | 0 | ||
CATALENT INC | COM | 148806102 | 58,385 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | ||
CELCUITY INC | COM | 15102K100 | 4,800 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 54,785 | 751,200 | SH | SOLE | 751,200 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 29,443 | 1,003,522 | SH | SOLE | 1,003,522 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,576 | 271,726 | SH | SOLE | 271,726 | 0 | 0 | ||
CM LIFE SCIENCES II INC | UNIT 02/25/2028 | 125842203 | 4,439 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
CM LIFE SCIENCES INC | COM CL A | 18978W109 | 7,355 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 38,150 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
CONFLUENT INC | CLASS A COM | 20717M103 | 4,750 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 38,700 | 1,808,394 | SH | SOLE | 1,808,394 | 0 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 6,754 | 86,100 | SH | SOLE | 86,100 | 0 | 0 | ||
DOXIMITY INC | CL A | 26622P107 | 8,730 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
DYNAMICS SPECIAL PURPOSE COR | CLASS A COM | 268010105 | 4,970 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 33,490 | 3,400,000 | SH | SOLE | 3,400,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 8,460 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 78,568 | 2,750,000 | SH | SOLE | 2,750,000 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 73,343 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | ||
FIGS INC | CL A | 30260D103 | 5,010 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
FLYWIRE CORPORATION | COM VTG | 302492103 | 1,837 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 12,169 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 22,602 | 735,500 | SH | SOLE | 735,500 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 19,374 | 2,122,064 | SH | SOLE | 2,122,064 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 20,805 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,080 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HEALTHCOR CATALIO ACQU CORP | CL A SHS | G44125105 | 4,925 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 4,140 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HOLOGIC INC | COM | 436440101 | 80,651 | 1,208,800 | SH | SOLE | 1,208,800 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 53,188 | 568,000 | SH | SOLE | 568,000 | 0 | 0 | ||
I MAB | SPONSORED ADS | 44975P103 | 61,200 | 729,000 | SH | SOLE | 729,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 43,449 | 2,070,000 | SH | SOLE | 2,070,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 23,469 | 601,000 | SH | SOLE | 601,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 32,730 | 1,150,050 | SH | SOLE | 1,150,050 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 7,728 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 61,526 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 8,834 | 1,400,010 | SH | SOLE | 1,400,010 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 35,970 | 9,294,600 | SH | SOLE | 9,294,600 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 25,656 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 4,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
LIFESTANCE HEALTH GROUP INC | COM | 53228F101 | 30,646 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 129,794 | 565,500 | SH | SOLE | 565,500 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 123,669 | 2,963,545 | SH | SOLE | 2,963,545 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 5,018 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 58 | 57,770 | SH | SOLE | 57,770 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 66,410 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 121,632 | 753,000 | SH | SOLE | 753,000 | 0 | 0 | ||
MONDAY COM LTD | SHS | M7S64H106 | 8,944 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 6,810 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 49,499 | 436,000 | SH | SOLE | 436,000 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 11,363 | 1,125,000 | SH | SOLE | 1,125,000 | 0 | 0 | ||
NEOGENOMICS INC | COM NEW | 64049M209 | 61,747 | 1,367,000 | SH | SOLE | 1,367,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 66,275 | 681,000 | SH | SOLE | 681,000 | 0 | 0 | ||
NEUROPACE INC | COM | 641288105 | 952 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 64,857 | 6,966,376 | SH | SOLE | 6,966,376 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 260 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
ONCOSEC MED INC | COM | 68234L306 | 7,868 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 16,602 | 3,781,798 | SH | SOLE | 3,781,798 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 5,008 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 7,452 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 16,052 | 4,315,000 | SH | SOLE | 4,315,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 9,357 | 182,000 | SH | SOLE | 182,000 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 15,307 | 778,597 | SH | SOLE | 778,597 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 15,162 | 2,060,000 | SH | SOLE | 2,060,000 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 101,043 | 640,000 | SH | SOLE | 640,000 | 0 | 0 | ||
SEASPINE HLDGS CORP | COM | 81255T108 | 31,278 | 1,524,998 | SH | SOLE | 1,524,998 | 0 | 0 | ||
SENTINELONE INC | CL A | 81730H109 | 8,500 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 56,246 | 1,940,200 | SH | SOLE | 1,940,200 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 18,095 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
SINGULAR GENOMICS SYSTEMS IN | COM | 82933R100 | 1,374 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLD CRPI | CLASS A ORD SHS | G8253W109 | 2,022 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 2,020 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253T106 | 2,022 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 2,024 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOTERA HEALTH CO | COM | 83601L102 | 46,279 | 1,910,000 | SH | SOLE | 1,910,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 79,240 | 4,615,000 | SH | SOLE | 4,615,000 | 0 | 0 | ||
SYNEOS HEALTH INC | CL A | 87166B102 | 15,661 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 6,410 | 436,363 | SH | SOLE | 436,363 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 39,819 | 4,105,000 | SH | SOLE | 4,105,000 | 0 | 0 | ||
UIPATH INC | CL A | 90364P105 | 20,379 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 42,413 | 236,400 | SH | SOLE | 236,400 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC. | COM | 92532F100 | 191,549 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 7,659 | 162,000 | SH | SOLE | 162,000 | 0 | 0 | ||
WALKME LTD | ORD SHS | M97628107 | 4,389 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 11,341 | 650,265 | SH | SOLE | 650,265 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 17,699 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 114,912 | 2,160,000 | SH | SOLE | 2,160,000 | 0 | 0 | ||
ZETA GLOBAL HOLDINGS CORP | CL A | 98956A105 | 10,920 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 |